European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F14%3AE0104317" target="_blank" >RIV/00843989:_____/14:E0104317 - isvavai.cz</a>

Alternative codes found

RIV/61988987:17110/14:A1501CGK

Result on the web

<a href="http://dx.doi.org/10.3324/haematol.2013.099358" target="_blank" >http://dx.doi.org/10.3324/haematol.2013.099358</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3324/haematol.2013.099358" target="_blank" >10.3324/haematol.2013.099358</a>

Result language

angličtina

Original language name

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

Original language description

Multiple myeloma management has undergone profound changes in the past thanks to advances in our understanding of the disease biology and improvements in treatment and supportive care approaches. This article presents recommendations of the European Myeloma Network for newly diagnosed patients based on the GRADE system for level of evidence. All patients with symptomatic disease should undergo risk stratification to classify patients for International Staging System stage (level of evidence: 1A) and forcytogenetically defined high-versus standard-risk groups (2B). Novel-agent-based induction and up-front autologous stem cell transplantation in medically fit patients remains the standard of care (1A). Induction therapy should include a triple combination of bortezomib, with either adriamycin or thalidomide and dexamethasone (1A), or with cyclophosphamide and dexamethasone (2B). Currently, allogeneic stem cell transplantation may be considered for young patients with high-risk disease a

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2014

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Haematologica

ISSN

0390-6078

e-ISSN

—

Volume of the periodical

99

Issue of the periodical within the volume

n. 2

Country of publishing house

IT - ITALY

Number of pages

11

Pages from-to

"p. 232-242"

UT code for WoS article

000336253900014

EID of the result in the Scopus database

—